IEQ Capital’s Ginkgo Bioworks DNA Stock Holding History

IEQ Capital’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$139K	Buy	+22,626	New	+$188K	﹤0.01%	1759
2024 Q3	–	Sell	-411	Closed	-$5.5K	–	1168
2024 Q2	$5.5K	Sell	411 -2	-0.5%	-$60	﹤0.01%	1001
2024 Q1	$19.1K	Buy	413 +20	+5%	+$1.03K	﹤0.01%	966
2023 Q4	$26.6K	Hold	393	–	–	﹤0.01%	918
2023 Q3	$28.5K	Hold	393	–	–	﹤0.01%	928
2023 Q2	$29.3K	Hold	393	–	–	﹤0.01%	890
2023 Q1	$20.9K	Sell	393 -1,046	-73%	-$66.3K	﹤0.01%	884
2022 Q4	$97.3K	Buy	+1,439	New	+$132K	﹤0.01%	770

Other funds holding DNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACG

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JMFC

J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

IEQ Capital's DNA Position: Q1 2026 in Review

IEQ Capital opened a new position in Ginkgo Bioworks (DNA) in Q1 2026: 22,626 shares worth $139K. The stake represents ﹤0.01% of the portfolio and ranks #1759 among its holdings. This is a return to the name: IEQ Capital previously reported a position in DNA as recently as Q2 2024.

IEQ Capital first reported a position in DNA in Q4 2022 and has held it in 8 quarters since. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

IEQ Capital held 22,626 shares of Ginkgo Bioworks worth $139K as of Q1 2026.
Ginkgo Bioworks was a new IEQ Capital position in Q1 2026.
Ginkgo Bioworks made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1759 holding.
IEQ Capital first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 8 quarters since.
174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.